{"id":"https://openalex.org/W3046293265","doi":"https://doi.org/10.1016/j.omto.2020.07.008","title":"Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for Immunotherapy","display_name":"Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for Immunotherapy","publication_year":2020,"publication_date":"2020-07-31","ids":{"openalex":"https://openalex.org/W3046293265","doi":"https://doi.org/10.1016/j.omto.2020.07.008","mag":"3046293265","pmid":"https://pubmed.ncbi.nlm.nih.gov/32913893","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7452143"},"language":"en","primary_location":{"id":"doi:10.1016/j.omto.2020.07.008","doi":"https://doi.org/10.1016/j.omto.2020.07.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omto.2020.07.008","pdf_url":"http://www.cell.com/article/S2372770520301121/pdf","source":{"id":"https://openalex.org/S2898235705","display_name":"Molecular Therapy \u2014 Oncolytics","issn_l":"2372-7705","issn":["2372-7705"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Oncolytics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.cell.com/article/S2372770520301121/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072569899","display_name":"Rory Crean","orcid":"https://orcid.org/0000-0003-4709-5353","observed_orcids":["https://orcid.org/0000-0003-4709-5353"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rory M. Crean","raw_affiliation_strings":["Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK","Doctoral Training Centre in Sustainable Chemical Technologies, University of Bath, Bath, BA2 7AY, UK","School of Biochemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]},{"raw_affiliation_string":"Doctoral Training Centre in Sustainable Chemical Technologies, University of Bath, Bath, BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]},{"raw_affiliation_string":"School of Biochemistry","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033682714","display_name":"Bruce J. MacLachlan","orcid":"https://orcid.org/0000-0002-2685-2733","observed_orcids":["https://orcid.org/0000-0002-2685-2733"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bruce J. MacLachlan","raw_affiliation_strings":["Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042114476","display_name":"Florian Madura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Florian Madura","raw_affiliation_strings":["Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013654674","display_name":"Thomas Whalley","orcid":"https://orcid.org/0000-0003-1375-4189","observed_orcids":["https://orcid.org/0000-0003-1375-4189"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Whalley","raw_affiliation_strings":["Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016792406","display_name":"P.J. Rizkallah","orcid":"https://orcid.org/0000-0002-9290-0369","observed_orcids":["https://orcid.org/0000-0002-9290-0369"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Pierre J. Rizkallah","raw_affiliation_strings":["Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061124996","display_name":"Christopher James Holland","orcid":"https://orcid.org/0000-0002-8741-9562","observed_orcids":["https://orcid.org/0000-0002-8741-9562"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher J. Holland","raw_affiliation_strings":["Immunocore, Ltd., Abingdon, OX14 4RY, UK","Immunocore Ltd., Milton Park, Abingdon, OX14 4RY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Ltd., Abingdon, OX14 4RY, UK","institution_ids":["https://openalex.org/I4210104024"]},{"raw_affiliation_string":"Immunocore Ltd., Milton Park, Abingdon, OX14 4RY, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057391722","display_name":"Catriona McMurran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catriona McMurran","raw_affiliation_strings":["Immunocore, Ltd., Abingdon, OX14 4RY, UK","Immunocore Ltd., Milton Park, Abingdon, OX14 4RY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Ltd., Abingdon, OX14 4RY, UK","institution_ids":["https://openalex.org/I4210104024"]},{"raw_affiliation_string":"Immunocore Ltd., Milton Park, Abingdon, OX14 4RY, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048042636","display_name":"Stephen J Harper","orcid":"https://orcid.org/0000-0002-6029-8668","observed_orcids":["https://orcid.org/0000-0002-6029-8668"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Harper","raw_affiliation_strings":["Immunocore, Ltd., Abingdon, OX14 4RY, UK","Immunocore Ltd., Milton Park, Abingdon, OX14 4RY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Ltd., Abingdon, OX14 4RY, UK","institution_ids":["https://openalex.org/I4210104024"]},{"raw_affiliation_string":"Immunocore Ltd., Milton Park, Abingdon, OX14 4RY, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012262326","display_name":"Andrew J Godkin","orcid":"https://orcid.org/0000-0002-1910-7567","observed_orcids":["https://orcid.org/0000-0002-1910-7567"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Godkin","raw_affiliation_strings":["Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008376558","display_name":"Andrew Kelvin Sewell","orcid":"https://orcid.org/0000-0003-3194-3135","observed_orcids":["https://orcid.org/0000-0003-3194-3135"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew K. Sewell","raw_affiliation_strings":["Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081272550","display_name":"Christopher R. Pudney","orcid":"https://orcid.org/0000-0001-6211-0086","observed_orcids":["https://orcid.org/0000-0001-6211-0086"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher R. Pudney","raw_affiliation_strings":["Centre for Therapeutic Innovation, University of Bath, Bath, BA2 7AY, UK","Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK","University of Bath"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Therapeutic Innovation, University of Bath, Bath, BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]},{"raw_affiliation_string":"Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]},{"raw_affiliation_string":"University of Bath","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021710523","display_name":"Marc W. van der Kamp","orcid":"https://orcid.org/0000-0002-8060-3359","observed_orcids":["https://orcid.org/0000-0002-8060-3359"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Marc W. van der Kamp","raw_affiliation_strings":["School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, UK","School of Biochemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Biochemistry","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022694581","display_name":"David K. Cole","orcid":"https://orcid.org/0000-0003-0028-9396","observed_orcids":["https://orcid.org/0000-0003-0028-9396"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]},{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"David K. Cole","raw_affiliation_strings":["Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","Immunocore, Ltd., Abingdon, OX14 4RY, UK","Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University"],"raw_orcid":"https://orcid.org/0000-0003-0028-9396","affiliations":[{"raw_affiliation_string":"Division of Infection & Immunity, Cardiff University, Cardiff, CF14 4XN, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Immunocore, Ltd., Abingdon, OX14 4RY, UK","institution_ids":["https://openalex.org/I4210104024"]},{"raw_affiliation_string":"Department of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University","institution_ids":["https://openalex.org/I79510175"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5021710523","https://openalex.org/A5022694581"],"corresponding_institution_ids":["https://openalex.org/I36234482","https://openalex.org/I4210104024","https://openalex.org/I79510175"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":0.8897,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.73228777,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"18","issue":null,"first_page":"443","last_page":"456"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0843999981880188,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.07240000367164612,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-receptor-engineering","display_name":"T cell receptor engineering","score":0.8100000023841858},{"id":"https://openalex.org/keywords/peptide-hla-complex","display_name":"peptide-HLA complex","score":0.7319999933242798},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/crystal-structure-comparison","display_name":"crystal structure comparison","score":0.5630000233650208},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/hydrophobic-residues","display_name":"hydrophobic residues","score":0.6850000023841858},{"id":"https://openalex.org/keywords/cascading-effects","display_name":"cascading effects","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C2780871342","wikidata":"https://www.wikidata.org/wiki/Q7883752","display_name":"Underpinning","level":2,"score":0.7879781723022461},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6675230264663696},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5977156758308411},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5121660232543945},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4542621970176697},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.43154793977737427},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4148627519607544},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32496926188468933},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2545401155948639},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24254801869392395},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.19240802526474},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12170052528381348},{"id":"https://openalex.org/C147176958","wikidata":"https://www.wikidata.org/wiki/Q77590","display_name":"Civil engineering","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1016/j.omto.2020.07.008","doi":"https://doi.org/10.1016/j.omto.2020.07.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omto.2020.07.008","pdf_url":"http://www.cell.com/article/S2372770520301121/pdf","source":{"id":"https://openalex.org/S2898235705","display_name":"Molecular Therapy \u2014 Oncolytics","issn_l":"2372-7705","issn":["2372-7705"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Oncolytics","raw_type":"journal-article"},{"id":"pmid:32913893","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32913893","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy oncolytics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7452143","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7452143/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther Oncolytics","raw_type":"Text"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/3355d67e-4016-46f4-b0bc-458f48f82bdd","doi":null,"is_oa":true,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/3355d67e-4016-46f4-b0bc-458f48f82bdd","pdf_url":null,"source":{"id":"https://openalex.org/S7407055359","display_name":"Explore Bristol Research","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Crean, R M, MacLachlan, B J, Madura, F, Whalley, T, Rizkallah, P J, Holland, C J, McMurran, C, Harper, S, Godkin, A, Sewell, A K, Pudney, C R, Van Der Kamp, M W & Cole, D K 2020, 'Molecular rules underpinning enhanced affinity binding of human T cell receptors engineered 2 for immunotherapy', Molecular Therapy, vol. 18, pp. 443-456. https://doi.org/10.1016/j.omto.2020.07.008","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire/3355d67e-4016-46f4-b0bc-458f48f82bdd","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1983/3355d67e-4016-46f4-b0bc-458f48f82bdd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Crean, R M, MacLachlan, B J, Madura, F, Whalley, T, Rizkallah, P J, Holland, C J, McMurran, C, Harper, S, Godkin, A, Sewell, A K, Pudney, C R, Van Der Kamp, M W & Cole, D K 2020, 'Molecular rules underpinning enhanced affinity binding of human T cell receptors engineered 2 for immunotherapy', Molecular Therapy, vol. 18, pp. 443-456. https://doi.org/10.1016/j.omto.2020.07.008","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:468343d29a914222a4306cde545a8b9d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/468343d29a914222a4306cde545a8b9d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 443-456 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.omto.2020.07.008","doi":"https://doi.org/10.1016/j.omto.2020.07.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omto.2020.07.008","pdf_url":"http://www.cell.com/article/S2372770520301121/pdf","source":{"id":"https://openalex.org/S2898235705","display_name":"Molecular Therapy \u2014 Oncolytics","issn_l":"2372-7705","issn":["2372-7705"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Oncolytics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.766700029373169,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1410343473","display_name":null,"funder_award_id":"mx6232-3","funder_id":"https://openalex.org/F4320320360","funder_display_name":"University of Bristol"},{"id":"https://openalex.org/G1910310239","display_name":null,"funder_award_id":"WT100327MA","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G260474477","display_name":null,"funder_award_id":"WT095767","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G3101364814","display_name":"Reducing transplant rejection by mapping the alloreactivity footprints of abundant virus-specific T-cell populations.","funder_award_id":"100327","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G8195738607","display_name":"Multi-scale enzyme modelling for SynBio: optimizing biocatalysts for selective synthesis of bioactive compounds","funder_award_id":"BB/M026280/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320318326","display_name":"Canolfan Ymchwil Canser Cymru","ror":"https://ror.org/03bfm0w23"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320320322","display_name":"University of Bath","ror":"https://ror.org/002h8g185"},{"id":"https://openalex.org/F4320320360","display_name":"University of Bristol","ror":"https://ror.org/0524sp257"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"},{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3046293265.pdf","grobid_xml":"https://content.openalex.org/works/W3046293265.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W1594353637","https://openalex.org/W1821172549","https://openalex.org/W1968984443","https://openalex.org/W1986216579","https://openalex.org/W1997222968","https://openalex.org/W1998415250","https://openalex.org/W2001641653","https://openalex.org/W2004550048","https://openalex.org/W2006922696","https://openalex.org/W2008295690","https://openalex.org/W2014275356","https://openalex.org/W2049204549","https://openalex.org/W2050698267","https://openalex.org/W2052586778","https://openalex.org/W2055736811","https://openalex.org/W2062073809","https://openalex.org/W2063184115","https://openalex.org/W2081090613","https://openalex.org/W2084883463","https://openalex.org/W2091567124","https://openalex.org/W2095719702","https://openalex.org/W2101553545","https://openalex.org/W2106582884","https://openalex.org/W2113488569","https://openalex.org/W2115770884","https://openalex.org/W2116117984","https://openalex.org/W2121487020","https://openalex.org/W2124985346","https://openalex.org/W2132826139","https://openalex.org/W2134724359","https://openalex.org/W2140574666","https://openalex.org/W2143626441","https://openalex.org/W2144081223","https://openalex.org/W2146040535","https://openalex.org/W2146914223","https://openalex.org/W2153478981","https://openalex.org/W2155740919","https://openalex.org/W2157384708","https://openalex.org/W2159772201","https://openalex.org/W2163341755","https://openalex.org/W2164382089","https://openalex.org/W2166213184","https://openalex.org/W2167642721","https://openalex.org/W2221713243","https://openalex.org/W2234384516","https://openalex.org/W2332712348","https://openalex.org/W2360792712","https://openalex.org/W2404280981","https://openalex.org/W2467278060","https://openalex.org/W2556032506","https://openalex.org/W2558508376","https://openalex.org/W2774553873","https://openalex.org/W2898119186","https://openalex.org/W2904572271","https://openalex.org/W2945822699","https://openalex.org/W2947027538","https://openalex.org/W2982586377","https://openalex.org/W2989616058","https://openalex.org/W2999528130","https://openalex.org/W3010111157","https://openalex.org/W3014980845","https://openalex.org/W3017309521"],"related_works":["https://openalex.org/W4412821547","https://openalex.org/W2124985346","https://openalex.org/W2063184115","https://openalex.org/W3175663815","https://openalex.org/W2167642721","https://openalex.org/W7171619193","https://openalex.org/W7171503863","https://openalex.org/W7166668539","https://openalex.org/W1482229658","https://openalex.org/W4404064752"],"abstract_inverted_index":{"Immuno-oncology":[0],"approaches":[1],"that":[2,113],"utilize":[3],"T":[4],"cell":[5,37],"receptors":[6],"(TCRs)":[7],"are":[8],"becoming":[9],"highly":[10,156],"attractive":[11],"because":[12,40],"of":[13,28,83,90,139,146,175,186],"their":[14,57,91],"potential":[15],"to":[16,55,100,130],"target":[17],"virtually":[18],"all":[19],"cellular":[20],"proteins,":[21],"including":[22],"cancer-specific":[23],"epitopes,":[24],"via":[25,126],"the":[26,36,71,80,103,107,131,137,147,169,182],"recognition":[27],"peptide-human":[29],"leukocyte":[30],"antigen":[31],"(pHLA)":[32],"complexes":[33],"presented":[34],"at":[35],"surface.":[38],"However,":[39],"natural":[41],"TCRs":[42,87,177,188],"generally":[43],"recognize":[44],"cancer-derived":[45],"pHLAs":[46],"with":[47,88],"very":[48],"weak":[49],"affinities,":[50],"efforts":[51],"have":[52],"been":[53],"made":[54],"enhance":[56],"binding":[58,115,124],"strength,":[59],"in":[60],"some":[61],"cases":[62],"by":[63,78],"several":[64],"million-fold.":[65],"In":[66],"this":[67],"study,":[68],"we":[69,95],"investigated":[70],"mechanisms":[72,105],"underpinning":[73],"human":[74],"TCR":[75],"affinity":[76,86,108,151],"enhancement":[77],"comparing":[79],"crystal":[81],"structures":[82],"engineered":[84,187],"enhanced":[85],"those":[89],"wild-type":[92],"progenitors.":[93],"Additionally,":[94],"performed":[96],"molecular":[97],"dynamics":[98],"simulations":[99],"better":[101],"understand":[102],"energetic":[104,144],"driving":[106],"enhancements.":[109],"These":[110],"data":[111],"demonstrate":[112],"supra-physiological":[114],"affinities":[116],"can":[117],"be":[118],"achieved":[119],"without":[120],"altering":[121],"native":[122],"TCR-pHLA":[123,148],"modes":[125],"relatively":[127],"subtle":[128],"modifications":[129],"interface":[132],"contacts,":[133],"often":[134,161],"driven":[135],"through":[136],"addition":[138],"buried":[140],"hydrophobic":[141],"residues.":[142,171],"Individual":[143],"components":[145],"interaction":[149],"governing":[150],"enhancements":[152],"were":[153],"distinct":[154],"and":[155,191],"variable":[157],"for":[158,181,194],"each":[159],"TCR,":[160],"resulting":[162],"from":[163],"additive,":[164],"or":[165],"knock-on,":[166],"effects":[167],"beyond":[168],"mutated":[170],"This":[172],"comprehensive":[173],"analysis":[174],"affinity-enhanced":[176],"has":[178],"important":[179],"implications":[180],"future":[183],"rational":[184],"design":[185],"as":[189],"efficacious":[190],"safe":[192],"drugs":[193],"cancer":[195],"treatment.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2020-08-07T00:00:00"}